MedicineWatch US
Class II Recall

SUN PHARMACEUTICAL INDUSTRIES INC

Product
buPROPrion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, 60 Tablets, Rx Only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ, Manufactured by: Sun Pharmaceutical Industries Limited, Gujrat, India, NDC 47335-737-86
Reason
Failed Dissolution Specifications; during stability testing
Classification
Class II
Status
Terminated
Lot
Lots: HAC2240A, Exp 05/2023; HAC3162A, Exp 07/2023
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.